-
L646152-25mgLaflunimus (C008B-270999)
Price: $729.61List Price: $810.68Laflunimus (HR325) is an immunosuppressive agent and an analogue of the Leflunomide-active metabolite A77 1726. Laflunimus is an orally active inhibitor of dihydroorotate dehydrogenase (DHODH). -
L646152-1mgLaflunimus (C008B-270998)
Price: $172.90List Price: $192.12Laflunimus (HR325) is an immunosuppressive agent and an analogue of the Leflunomide-active metabolite A77 1726. Laflunimus is an orally active inhibitor of dihydroorotate dehydrogenase (DHODH). -
Ab337439-50μgRecombinant Neutrophil Elastase Antibody (C008B-270997)
Price: $656.64List Price: $729.59Recombinant Neutrophil Elastase Antibody (C008B-270997) -
Ab337439-1mgRecombinant Neutrophil Elastase Antibody (C008B-270996)
Price: $6,662.22List Price: $7,402.47Recombinant Neutrophil Elastase Antibody (C008B-270996) -
Ab337439-10μgRecombinant Neutrophil Elastase Antibody (C008B-270995)
Price: $274.42List Price: $304.92Recombinant Neutrophil Elastase Antibody (C008B-270995) -
Ab337439-100μgRecombinant Neutrophil Elastase Antibody (C008B-270994)
Price: $1,045.82List Price: $1,162.03Recombinant Neutrophil Elastase Antibody (C008B-270994) -
M730530-50mg(3-Bromo-2,6-difluorophenyl)methanol
Price: $19.80List Price: $22.00(3-Bromo-2,6-difluorophenyl)methanol -
M701185-50mg(2,6-Dimethylpyridin-3-yl)methanol
Price: $19.80List Price: $22.00(2,6-Dimethylpyridin-3-yl)methanol -
M725011-50mgMethyl 2-phenylnicotinate (C008B-270991)
Price: $75.80List Price: $84.22Methyl 2-phenylnicotinate (C008B-270991) -
M725011-250mgMethyl 2-phenylnicotinate (C008B-270990)
Price: $160.79List Price: $178.65Methyl 2-phenylnicotinate (C008B-270990) -
M725011-1gMethyl 2-phenylnicotinate (C008B-270989)
Price: $360.49List Price: $400.54Methyl 2-phenylnicotinate (C008B-270989) -
I651771-25mgImanixil (C008B-270988)
Price: $1,191.77List Price: $1,324.19Imanixil (HOE-402 free base) is an inducer of the LDL receptor (LDLR). Imanixil (HOE-402 free base) is also a potent cholesterol-lowering compound, which inhibits very low density-lipoprotein (VLDL) production, and consequently attenuates...